The US Food and Drug Administration has issued guidance urging sponsors and trial sites to consider the necessity of the invasive procedure.
CytoMed Therapeutics has signed a business and research collaboration agreement with SunAct Cancer Institute for a clinical trial in India.
VYNE Therapeutics has completed enrolment in the randomised Phase IIb clinical trial of VYN201 gel for treating non-segmental vitiligo.
After disappointing Phase IIb results for avicursen in December, Percheron will adopt a three-pronged business strategy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback